Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 28, 2017 - Issue 3
Submit an article Journal homepage
2,978
Views
20
CrossRef citations to date
0
Altmetric
Psoriasis & Related Studies

Patient-reported impact of chronic urticaria compared with psoriasis in theUnited States

Meryl H. MendelsonNovartis Pharmaceutical Corporation, East Hanover, NJ, USA;
,
Jonathan A. BernsteinDepartment of Medicine, University of Cincinnati, Cincinnati, OH, USA;
,
Susan GabrielNovartis Pharmaceutical Corporation, East Hanover, NJ, USA;
,
Maria-Magdalena BalpGlobal HEOR, Novartis Pharma AG, Basel, Switzerland;
,
Haijun TianNovartis Pharmaceutical Corporation, East Hanover, NJ, USA;
,
Jeffrey VietriHealth Economics, Kantar Health, Horsham, PA, USA; Correspondence[email protected]
&
Mark LebwohlDepartment of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
 show all
Pages 229-236 | Received 27 May 2016, Accepted 05 Aug 2016, Published online: 15 Sep 2016

References

  • Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69:868–87.
  • Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy. 2011;66:317–30.
  • Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270–7.
  • Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2012;4:326–31.
  • Barbosa F, Freitas J, Barbosa A. Chronic idiopathic urticaria and anxiety symptoms. J Health Psychol. 2011;16:1038–47.
  • Engin B, Uguz F, Yilmaz E, et al. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2008;22:36–40.
  • Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004;59:869–73.
  • Vietri J, Turner SJ, Tian H, et al. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey. Ann Allergy Asthma Immunol. 2015;115:306–11.
  • Balp MM, Vietri J, Tian H, Isherwood G. The impact of chronic urticaria from the patient's perspective: a survey in five European countries. Patient. 2015;8:551–8.
  • Cohen BE, Martires KJ, Ho RS. Psoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009–2012. JAMA Dermatol. 2016;152:73–9.
  • Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med. 2009;121:154–61.
  • Wahl A, Loge JH, Wiklund I, Hanestad BR. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol. 2000;43:803–8.
  • The National Health and Wellness Survey Fact Sheet. 2015. Available from http://www.kantarhealth.com/docs/datasheets/Kantar_Health_NHWS_datasheet%20.pdf. Accessed January 13 2016.
  • About Psoriasis 2016. Available from https://www.psoriasis.org/about-psoriasis. Accessed February 10 2016.
  • Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to Score Version 2 of the SF-12 Health Survey. Lincoln: QualityMetric, Inc., 2002.
  • Maruish M, ed. User's Manual for the SF-36v2 Health Survey, 3rd ed. Lincoln: QualityMetric, Inc., 2011.
  • Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–9.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353.
  • Broder MS, Raimundo K, Antonova E, Chang E. Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria. Am J Clin Dermatol. 2015;16:313–21.
  • Zuberbier T, Balke M, Worm M, et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35:869–73.
  • Grob JJ, Revuz J, Ortonne JP, et al. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol. 2005;152:289–95.
  • O'Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197–201.
  • Staubach P, Dechene M, Metz M, et al. High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol. 2011;91:557–61.
  • Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res. 2009;18:415–22.
  • Liu GG, DiBonaventura M, Yuan Y, et al. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value Health. 2012;15:S65–S71.
  • Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140:667–71.
  • Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294–8.
  • Weller K, Maurer M, Grattan C, et al. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015;5:29.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.